Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07807176

Neuromodulation Combined With Dual FES Cycling and Cognitive Training After Stroke

This study will evaluate the effects of functional electrical stimulation (FES) cycling, cognitive task training, and non-invasive photobiomodulation on cognitive and upper-limb motor performance in adults after stroke. The study includes three stages to identify favorable FES cycling and neuromodulation approaches and to evaluate their combined effects. Participants will complete 10 intervention sessions over 2 weeks. Cognitive and motor outcomes will be assessed before treatment, immediately after treatment, and at 3-month follow-up. Feasibility, tolerance, and adverse events will also be evaluated.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This is a three-stage, randomized, sham-controlled study in individuals after stroke. Stage 1 will compare FES cycling alone, FES cycling combined with cognitive task training, and sham FES cycling. Stage 2 will compare photobiomodulation applied to the ear, forehead, and sham stimulation. Stage 3 will evaluate the selected FES cycling and neuromodulation approaches alone and in combination. Participants will complete 10 sessions over 2 weeks. Cognitive, upper-extremity motor, functional, participation, and quality-of-life outcomes will be assessed at baseline, immediately after treatment, and at 3-month follow-up. Feasibility, adherence, tolerance, and adverse events will also be monitored.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 20 to 80 years.
  • First-ever ischemic or hemorrhagic stroke with unilateral impairment in hand or arm strength or motor function.
  • Medically stable and able to participate safely in the training program.
  • Able to understand the study procedures and sign the informed consent form.
  • Able to follow verbal instructions, comply with study procedures, and complete all assessments.
  • Able to maintain a seated position and participate in each training session (approximately 40-60 minutes).

Exclusion criteria

  • Stroke involving the brainstem or cerebellum.
  • History of epilepsy, photosensitive epilepsy, or a tendency to faint.
  • Presence of implanted electronic devices, such as pacemakers, implantable cardioverter-defibrillators (ICD), or other electronic medical implants (e.g., artificial heart, infusion pumps, cochlear implants).
  • Wounds, infections, or significant skin problems at potential stimulation sites (ear or scalp).
  • Presence of major psychiatric disorders or inability to understand or cooperate with testing.
  • Cardiovascular or vascular-related conditions, including severe heart disease, uncontrolled arrhythmia, or medical advice against exercise; use of anticoagulant medication that makes laser stimulation inappropriate.
  • Acute illness, such as fever or active infection.
  • Botulinum toxin injections or relevant surgeries within the past six months.
  • Photosensitive disorders (e.g., lupus, porphyria) or current use of photosensitizing medications.
  • Inability to safely perform cycling training (e.g., recent fractures, severe spasticity, difficulty maintaining seated posture).
  • Pregnant or breastfeeding individuals.
  • Any other condition deemed unsuitable by the study physician (e.g., severe claustrophobia).

Treatment and study plan

Functional Electrical Stimulation Cycling

Device

FES-assisted arm cycling is provided for approximately 40 minutes per session, 5 sessions per week for 2 weeks.

Cognitive Task Training

Behavioral

Cognitive tasks are performed during FES cycling and progressively target attention, working memory, and executive control.

Transcutaneous Auricular Photobiomodulation

Device

Photobiomodulation is applied to the outer ear for approximately 20 to 30 minutes.

Transcutaneous Forehead Photobiomodulation

Device

Photobiomodulation is applied to the forehead for approximately 20 to 30 minutes.

Sham Functional Electrical Stimulation Cycling

Device

Participants receive the sham FES cycling control condition.

Sham photobiomodulation

Device

Participants receive the sham photobiomodulation control condition.

Optimal FES Cycling Protocol

Other

The FES cycling condition associated with the most favorable cognitive-motor performance pattern in Stage 1 will be selected for use in Stage 3. The selected protocol will consist of either FES cycling alone or FES cycling combined with cognitive task training.

Optimal Neuromodulation Protocol

Device

The photobiomodulation condition associated with the most favorable cognitive-motor performance pattern in Stage 2 will be selected for use in Stage 3. The selected protocol will consist of either transcutaneous auricular photobiomodulation (taPBM) or transcutaneous forehead photobiomodulation (tfPBM).

Primary outcomes

  1. Trail Making Test-Part B (TMT-B)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The TMT-B assesses executive function and cognitive flexibility. Longer completion times indicate poorer executive function and cognitive flexibility.

  2. Intra-Extra Dimensional Shift (IED)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The IED assesses set-shifting ability and cognitive flexibility. Fewer errors indicate better performance.

  3. Rapid Visual Information Processing (RVP)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The RVP assesses sustained attention. Higher accuracy indicates better sustained attention.

  4. Digit Span Test

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The Digit Span Test assesses working memory and sustained attention. Higher span scores indicate stronger working memory and sustained attention.

  5. Fugl-Meyer Assessment-Upper Extremity (FMA-UE)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The FMA-UE assesses upper-extremity motor control. Scores range from 0 to 66, with higher scores indicating better motor control.

  6. Action Research Arm Test (ARAT)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The ARAT assesses upper-limb functional performance. Scores range from 0 to 57, with higher scores indicating better upper-limb function.

Secondary outcomes

  1. Montreal Cognitive Assessment (MoCA)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The MoCA assesses cognitive functioning across domains including attention, executive function, memory, and visuospatial skills. Scores range from 0 to 30, with higher scores indicating better cognitive functioning.

  2. Trail Making Test-Part A (TMT-A)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The TMT-A assesses processing speed and attention. Longer completion times indicate poorer processing speed and attention.

  3. Symbol Digit Modalities Test (SDMT)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The SDMT assesses processing speed. More correct responses indicate better processing speed.

  4. Spatial Working Memory (SWM)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The SWM assesses working memory. Fewer errors indicate better working memory performance.

  5. Paired Associates Learning (PAL)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The PAL assesses visual learning. Fewer errors indicate better visual learning performance.

  6. Modified Ashworth Scale (MAS)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The MAS assesses muscle spasticity. Scores range from 0 to 4, with higher scores indicating greater spasticity.

  7. Grip and Pinch Dynamometry

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    Grip and pinch dynamometry measures upper-extremity muscle strength. Higher force output indicates greater muscle strength.

  8. Box and Block Test (BBT)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The BBT assesses gross manual dexterity. More blocks transferred indicate better gross manual dexterity.

  9. Nine-Hole Peg Test (9HPT)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The 9HPT assesses fine motor coordination. Shorter completion times indicate better fine motor coordination.

  10. Motor Activity Log (MAL)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The MAL assesses use of the affected arm in daily activities and perceived quality of movement. Scores range from 0 to 5, with higher ratings indicating greater daily arm use and better movement quality.

  11. ABILHAND Questionnaire

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The ABILHAND Questionnaire assesses perceived manual ability in daily activities. Higher logit scores indicate better perceived manual ability.

  12. Functional Independence Measure (FIM)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The FIM assesses functional independence. Scores range from 18 to 126, with higher scores indicating greater functional independence.

  13. Stroke Impact Scale (SIS)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The SIS assesses the impact of stroke on functional recovery. Domain scores range from 0 to 100, with higher scores indicating better functional recovery.

  14. Stroke-Specific Quality of Life Scale (SS-QOL)

    Time frame: Baseline (T0), immediately after the 2-week intervention (T1), and 3-month follow-up (T2).

    The SS-QOL assesses stroke-specific health-related quality of life. Higher scores indicate better health-related quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Chia-Ling Chen

CONTACT

[email protected]

+883-3-3281200 ext. 8148

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Registry information

Official study title

Exploratory Evaluation of Neuromodulation Combined With Dual Functional Electrical Stimulation Cycling and Cognitive Task Training on Cognitive-Motor Performance in Individuals After Stroke

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 8, 2026
Registry last updated
Sep 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.